Withdrawing drugs: nefazodone, the start of the latest saga

@article{Edwards2003WithdrawingDN,
  title={Withdrawing drugs: nefazodone, the start of the latest saga},
  author={Ivor Ralph Edwards},
  journal={The Lancet},
  year={2003},
  volume={361}
}
  • I. Edwards
  • Published 12 April 2003
  • Medicine
  • The Lancet

Topics from this paper

A 3D cell printing-fabricated HepG2 liver spheroid model for high-content in situ quantification of drug-induced liver toxicity.
TLDR
The results demonstrate that the present 3D cell-printing-based embedded HepG2 liver spheroid platform is a promising approach for screening and characterizing drug-induced hepatotoxicity.
Leveraging genetic data to investigate molecular targets and drug repurposing candidates for treating alcohol use disorder and hepatotoxicity.
TLDR
This study demonstrates the value of incorporating regulatory information and drug-protein interaction data to highlight additional molecular targets and drug repurposing candidates for treating AUD and ALD.
Leveraging genetic data to investigate molecular targets and drug repurposing candidates for treating alcohol use disorder and hepatotoxicity
TLDR
This study demonstrates the value of incorporating regulatory information and drug-protein interaction data to highlight additional molecular targets and drug repurposing candidates for treating AUD and ALD.
Novel molecular targets for treating alcohol use disorder and hepatotoxicity
TLDR
The value of incorporating regulatory information and drug-protein interaction data to highlight promising molecular targets and drugs for treating AUD and ALD is demonstrated.
Endoplasmic Reticulum Stress Induction and ERK1/2 Activation Contribute to Nefazodone-Induced Toxicity in Hepatic Cells.
TLDR
It is suggested that ER stress contributes to nefazodone-induced toxicity in HepG2 cells and that the MAPK signaling pathway plays an important role in ER stress.
Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma.
While conventional parameters used to detect hepatotoxicity in drug safety assessment studies are generally informative, the need remains for parameters that can detect the potential for
Depression and antidepressants in Australia and beyond: A critical public health analysis
TLDR
A detailed case-study analyses how key players, including prominent psychiatrists and consumer advocacy organisations and pharmaceutical companies, have succeeded in making depression a central focus of Australian mental health policy, fuelling the boom in antidepressant prescribing.
Pharmacovigilance: healthcare professionals' role in benefits versus harm analysis of drugs use.
TLDR
This review aims to sensitize Caribbean healthcare professionals to the global pharmacovigilance network of the World Health Organization and how their active involvement at the national level is imperative to the benefit versus harm evaluation of drugs.
...
1
2
...

References

SHOWING 1-9 OF 9 REFERENCES
The Science and Politics of Medicines Control
TLDR
It is argued that, in principle, toxicology, clinical pharmacology and pharmacovigilance in drug testing and regulation are necessarily a combination of science and politics and this has important implications for how one attempts to make progress in drug regulation.
Labelling and ‘Dear Doctor’ Letters
TLDR
Over the past few years, a number of drugs have been withdrawn for safety reasons, either by drug approval authorities, or by the manufacturer, not because the nature of the risk involved was unknown but because the risk had proved apparently uncontainable.
Factors controlling the loss of immunoreactive somatic histone H1 from blastomere nuclei in oocyte cytoplasm: a potential marker of nuclear reprogramming.
TLDR
Results indicate that evolutionarily conserved cell-cycle-regulated activities, nuclear elements, and phosphorylation-linked events participate in the depletion of immunoreactive histone H1 from blastomere nuclei transferred in oocyte cytoplasm and that this is linked to changes in gene expression in the transferred nucleus.
Liver enzyme monitoring in patients treated with troglitazone.
TLDR
The FDA risk management efforts did not achieve meaningful or sustained improvement in liver enzyme testing and Evaluation of the impact of regulatory actions is needed before such actions can be regarded as effective or sufficient.
Contraindicated use of cisapride: impact of food and drug administration regulatory action.
TLDR
The FDA's 1998 regulatory action regarding cisapride use had no material effect on contraindicated cisap Ride use and more effective ways to communicate new information about drug safety are needed.
Non-steroidal anti-inflammatory drugs
TLDR
Bias is common in the design and analysis of the trials, to such an extent that a systematic review identified false significant findings favouring new drugs over control drugs in 6% of trials.
The Challenge of Effectively Communicating Risk-Benefit Information
SummaryAlthough the techniques involved in drug safety monitoring (pharmacovigilance) have dramatically improved in recent years, communication of these issues to health professionals and the public